WhatsApp Group Join Now
Telegram Group Join Now

India’s BioEconomy Booster Dr. Jitendra Singh (BioE3)

Recently Approved BioE3 Policy by Union Cabinet Under Chairmanship PM Narendra Modi, Aims for Higher Biomanufacturing With Less Carbon Economy i.e “Net Zero” And Mission Life (Environment Lifestyle).

India's BioEconomy Booster Dr. Jitendra Singh

Indian Bioeconomy was 10 Billion USD in 2014 And Now In 2024 Its 130 US Billion And Its Estimated Projection Is 300 Billion Till 2030.

Dr. Jitendra Singh 18th Minister of Science and Technology and Minister of Earth Sciences Formally Released BioE3 Policy at L Media Centre Today.

Dr. Jitendra Singh Said

“India’s bio-economy skyrockets from USD 10 billion in 2014 to over USD 130 billion in 2024, with projections to reach USD 300 billion by 2030”

He Also Said That “BioE3 Newly Introduced Policy Will Skyrocket our Bio-economy as Will It Be a Game Changer For “Viksit Bharat @2047”.

According To the Ministry of Science and Technology and the Minister of Earth Sciences, During the Ceremony, Dr. Jitendra Hailed India as a Global Biotech Powerhouse By Crediting To PM Narendra Modi’s Vision Their Leadership, And This Transformative Journey. He also said that PM Modi Will be Hailed As the Champion of the New Biotech Boom Across the World.

Dr. Jitendra Singh Also Highlighted Impact of BioE3 Policy Across Various Sector Such as Food, Energy, Health, Biotech and Pharma Industry.

This Policy Is Based on six thematic Areas: Bio-based Chemicals And Enzymes, Smart Proteins, Functional Food, Climate-resilient Agriculture, Precision Biotherapeutics, Carbon Capture and Utilisation, And Futuristic Marine and Space Research.

He also Focus Attention on Public Private Partnership (PPP) Model Will be Integral to policy implementation, Incentivizing Industry Participations and Promoting Employment Generations.

Singh said, “its the best Time for Biotech, Highlighting the Progress of Biotechnology in India”.

He also Focuses attention on India’s Resources and Said, “India is a Huge Wealth of Bioresources, an Unsaturated Resource Waiting to Be harnessed and an Advantage in Biotech, Especially Due to Vast Biodiversity and Unique Bioresources in Himalayas. there is a 7,500 Km 7,500-long coastline, and Last Year India Launched a Deep sea Mission, that will help to dig Biodiversity Beneath the Seas.

See also  AI Demand Increasing in Indian Healthcare And Pharma

He also said that “IT Revolution Was West Driven the Biotech Revolution Will be India Driven”.

He recalled the successes of the previous ten years, including the explosive growth of India’s bioeconomy, which went from USD 10 billion in 2014 to over USD 130 billion in 2024 and is expected to reach USD 300 billion by 2030. He reiterated that biotechnology holds great promise for spearheading the next 21st-century revolution.

For the release and media interaction, Dr. VK Saraswat, Member (S&T) Niti Ayog, and Dr. Rajesh Gokhale, Secretary, Department of Biotechnology, were also present.

Working As Reporter on Pharmabharat.com And Part of Biocon Pharmaceuticals Team. Love To Give Updates On Stocks, News, Jobs, Internships, Scholarships

Leave a Comment